U.S. Contraceptive Market Forecast to 2030 with Key Companies Profile

U.S. Contraceptive Industry Overview

The U.S. contraceptive market size was valued at around USD 8.0 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of around 4.70% in the forecast period.

Increase in the use of modern contraceptives and rise in awareness among adolescents and the young population about sexual health and family planning are key factors that driving the U.S. market growth. Moreover, government programs have led to an increase in access to contraceptives that help prevent unwanted pregnancies in teenagers.

Gather more insights about the market drivers, restrains and growth of the U.S. Contraceptive Market

U.S. Contraceptive Market size, by product, 2020 - 2030 (USD Billion)

Development, approval, and commercialization of new, more effective, and long-acting reversible contraceptive methods are expected to drive the industry scale during the forecast period. For instance, Agile Therapeutics developed a hormonal patch, Twirla, which was introduced in the U.S. in the fourth quarter of 2020. The launch of generic and low-cost drugs and devices has led to an increase in the demand for contraceptives by teenagers as well. Furthermore, the demand for nonhormonal contraceptives in the U.S. is increasing since they eliminate the risk of adverse effects associated with hormonal imbalance in the body.

Improving access to Family Planning and Reproductive Health (FP/RH) services can have a positive impact on the economy as the number of unintended pregnancies and maternal deaths would be limited. The U.S. government supports global FP/RH efforts which is one of the largest distributors and purchasers of contraceptives.

In 29 U.S. states, insurers are required to provide a full range of coverage for FDA-approved contraceptive methods for women. In 12 states, over-the-counter contraceptives are covered; however, insurers may require a prescription from the beneficiary. In 20 states and the District of Columbia, insurers are required to cover an extended supply of contraceptives at one time.

The COVID-19 pandemic has significantly impacted the U.S. healthcare sector. The contraceptives market is majorly dependent on physician-prescribed and physician-administered products. Due to restrictions on visiting physician offices without an emergency the demand for contraceptive products was low during the first few months of the pandemic. Telehealth services and virtual consultations were recommended for contraceptive screening and counseling.

Furthermore, demand for nonhormonal contraceptives in young women is expected to increase as they want to avoid risks associated with hormonal contraceptives. Newly developed products, such as nonhormonal vaginal rings, diaphragms, and innovative condoms, are expected to aid the growth of the nonhormonal products segment during the forecast period.

Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Biopsy Devices Market - The global biopsy devices market size was valued at USD 2.11 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030.
  • Osteosynthesis Devices Market - The global osteosynthesis devices market size is valued at USD 9.23 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030.

Market Share Insights

  • July 2020: TherapeuticsMD, Inc. entered into an agreement with Nurx—an online company for women’s health-for increasing its access to Annovera. High investments by prominent companies for the commercialization of effective and long-term reversible contraceptives have increased the awareness levels about these products.
  • February 2020: Afaxys, Inc. and TherapeuticsMD, Inc. signed an agreement to increase access to Annovera in the U.S. public healthcare system.

Key Companies profiled:

Some prominent players in the U.S. contraceptive market include

  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group Plc
  • Veru, Inc.
  • Organon Group Of Companies
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • The Cooper Companies, Inc.
  • Mayer Laboratories, Inc.
  • Agile Therapeutics
  • TherapeuticsmMD, Inc.
  • Bayer Ag
  • Afaxys, Inc.
  • Mithra Pharmaceuticals
  • Abbvie

Order a free sample PDF of the U.S. Contraceptive Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

South Africa Veterinary Medicine Market Size, Share, Revenue Analysis By 2028

Image
South Africa Veterinary Medicine Industry Overview The  South Africa veterinary medicine market  size is expected to reach USD 248.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.1% from 2021 to 2028. The market holds many opportunities to grow during the forecast period owing to the growing livestock and pet population, increasing consumption of meat, rising incidence of diseases in animals, and the presence of key global companies. According to a report published by the African Union/Interafrican Bureau for Animal Resources (AU/IBAR), MSD Animal Health leads the South African market for veterinary medicines, followed by other key companies. South Africa Veterinary Medicine Market Segmentation Grand View Research has segmented the South Africa veterinary medicine market on the basis of animal type, product, mode of delivery, and end-use: Based on the Animal Type Insights, the market is segmented i...
Read more

U.S. Cold Storage Market Distributor Analysis and Forecasts By 2030

Image
U.S. Cold Storage Market Growth & Trends The  U.S. cold storage market  size is estimated to reach USD 96.90 billion by 2030, expanding at a CAGR of 13.6% over the forecast period, according to the new research conducted by Grand View Research, Inc. The U.S. is widely regarded as one of the leading markets in developing technologies responsible for the effective management of cold storage processes. The pharmaceutical industry is expected to offer growth opportunities to the market. Inventory management of pharmaceutical goods, such as vaccines   and medicines, is an expensive process that necessitates adequate security measures to maintain product quality. Advanced cold storage technologies that offer beneficial features, such as advanced refrigeration technologies and monitoring and tracking systems of various products like fruits and vegetables, significantly mitigate the possibility of wastage of temperature-sensitive goods. U.S. Cold Storage Market S...
Read more

Fencing Market Competitive Landscape And Component Benchmarking 2030

Image
Fencing Market Growth & Trends The global  fencing market  size is anticipated to reach USD 44.39 billion by 2030, growing at a CAGR of 5.5% over the forecast period, according to a new report by Grand View Research, Inc. The growing need to safeguard agricultural assets and the aggressive investments being made by private companies in strengthening the security and enhancing the aesthetics of their premises are expected to drive the growth of the market over the forecast period. The growth of the  real estate market  and the increase in the number of remodeling projects being undertaken are expected to contribute to the growth of the market. Fencing Market Segmentation Grand View Research has segmented the global fencing market based on material, distribution channel, installation, application, end use, and region: Based on the Material Insights, the market is segmented into Metal, Wood, Plastic & Composite, Concrete. The metal segment accounted for ...
Read more